secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACURA PHARMACEUTICALS, INC (—)
CIK:        0000786947
Form:       8-K
Filed at:   2025-10-24T23:59:59+00:00
Accession:  0001104659-25-101984
Event type: debt
Sentiment:  negative
Materiality: 0.85
Item codes: 1.01, 2.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Acura borrows additional $300k from AD Pharma; warns of potential bankruptcy by early Nov 2025
--------------------------------------------------------------------------------

- Principal balance on amended secured note reaches $8,994,279, with ~$865k accrued interest at 5.25%.
- Three new $100k loans from AD Pharma (Sept 12, Oct 6, Oct 23 2025) used for day-to-day operations.
- Without additional financing by early November 2025, company will need to scale back, furlough or terminate operations.
- AD Pharma, which owns ~65% of Acura's common stock, is controlled by Mr. Schutte.
- Interest rate on overdue amounts jumps to 7.5% per annum upon default.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/786947/000110465925101984/0001104659-25-101984-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/786947/000110465925101984/tm2529376d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-101984

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer